The Limited Times

Now you can see non-English news...

Israeli breakthrough in the treatment of lung cancer Israel today

2022-02-10T10:41:35.071Z


The Israeli researcher, Dr. Elizabeth Dudnik, showed that rare cancer can be treated using a medical method called immunotherapy. • The treatment reduces the risk of mortality by 42 percent and leads to long-term survival.


A breakthrough regarding the treatment of one of the most dangerous and violent lung cancers usually caused by smoking.

This is a real hope for patients who to this day have barely recovered from the disease.

In a scientific publication in the prestigious journal, researcher Dr. Elizabeth Dodnik, head of breast cancer at Assuta, showed that the rare cancer that attacks human lungs called the Journal of Immunotherapy of Cancer can be promisingly treated by an advanced medical method called immunotherapy.

To date this rare cancer, which is 3% more common among lung cancers, has usually been detected at a stage where it is very widespread and there is no way to stop it by surgery.

This reality greatly affected his lethality and the difficulty of rescuing his patients who were identified in a very serious condition of the disease.

Another problem of this cancer was due to a lack of clinical information about it due to its rarity, so it was not known which treatments were able to deal with it.

In relation to this, Dr. Dudnik showed that artotherapy in parallel with regular chemotherapy works against cancer, reduces the risk of mortality by 42 percent and leads to higher long-term survival than chemotherapy.

Dr. Elizabeth Dodnik, Photo: Victoria Manushirov

What is artistic therapy

Artotherapy, known to the medical world for about five years and is better in regular cancers including lung cancers than chemotherapy.

It is a drug that releases the brakes of the body's immune system and therefore gives the body's immune system more power and strength.

This is a significant treatment that has been well proven in the fight against cancer but in relation to this unique lung cancer there was not enough information due to the small number of patients.

"My breakthrough is that I was able to gather enough information and give new hope to these patients with violent and very rare cancer. So far these patients have been in a bad condition because it was not known how to treat them. The next step is a combination of chemotherapy and art therapy to save my son "Man," the researcher told Israel Today.

The present study was conducted in collaboration with researchers from Georgetown University Hospital and included the largest series in the scientific literature of patients with this cancer 125 patients.

Were we wrong?

Fixed!

If you found an error in the article, we'll be happy for you to share it with us

Source: israelhayom

All life articles on 2022-02-10

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.